Cellectar Biosciences Statistics

Total Valuation

CLRB has a market cap or net worth of $85.32 million. The enterprise value is $45.84 million.

Market Cap	85.32M
Enterprise Value	45.84M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CLRB has 35.85 million shares outstanding. The number of shares has increased by 160.60% in one year.

Shares Outstanding	35.85M
Shares Change (YoY)	+160.60%
Shares Change (QoQ)	+140.12%
Owned by Insiders (%)	3.20%
Owned by Institutions (%)	25.56%
Float	26.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.26
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.02.

Current Ratio	2.54
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,855.60% and return on invested capital (ROIC) is -158.18%.

Return on Equity (ROE)	-1,855.60%
Return on Assets (ROA)	-245.60%
Return on Capital (ROIC)	-158.18%
Revenue Per Employee	n/a
Profits Per Employee	-$2.55M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-60,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.67% in the last 52 weeks. The beta is 1.00, so CLRB's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	+16.67%
50-Day Moving Average	3.06
200-Day Moving Average	3.05
Relative Strength Index (RSI)	36.52
Average Volume (20 Days)	560,251

Short Selling Information

The latest short interest is 2.37 million, so 6.60% of the outstanding shares have been sold short.

Short Interest	2.37M
Short Previous Month	2.17M
Short % of Shares Out	6.60%
Short % of Float	8.86%
Short Ratio (days to cover)	5.65

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.26M
Pretax Income	-51.04M
Net Income	-50.98M
EBITDA	-50.75M
EBIT	-51.04M
Earnings Per Share (EPS)	-$3.08

Full Income Statement

Balance Sheet

The company has $40.03 million in cash and $548,343 in debt, giving a net cash position of $39.48 million or $1.10 per share.

Cash & Cash Equivalents	40.03M
Total Debt	548,343
Net Cash	39.48M
Net Cash Per Share	$1.10
Equity (Book Value)	26.17M
Book Value Per Share	0.73
Working Capital	25.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.55 million and capital expenditures -$885,671, giving a free cash flow of -$39.44 million.

Operating Cash Flow	-38.55M
Capital Expenditures	-885,671
Free Cash Flow	-39.44M
FCF Per Share	-$1.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-160.60%
Shareholder Yield	-160.60%
Earnings Yield	-59.76%
FCF Yield	-46.23%

Analyst Forecast

The average price target for CLRB is $20.00, which is 740.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	740.34%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 1:10.

Last Split Date	Jul 22, 2022
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	3